Support for Your Mammalian-Based Therapeutics and Vaccines
There’s good reason mammalian cell expression systems drive many of today’s successful pharmaceutical innovations. They’re not only ideal for high-volume manufacturing of therapeutic proteins and viral vaccines, but they also serve as the platform of choice for next-generation cell and gene therapies. At Emergent CDMO, our mammalian drug substance development and manufacturing teams are ready to work closely with you to deliver a solution honed to your specific needs.
We help biopharma organizations of all sizes — from small start-ups and research labs to global pharmaceutical companies —successfully manage the development and manufacturing processes required for mammalian cell expression systems to produce a variety of high-quality therapeutic proteins.